HIGHLIGHTS
- who: Lauren Turza from the University of Texas Southwestern Medical Center, United States have published the article: Eligibility, uptake and response to germline genetic testing in women with DCIS, in the Journal: (JOURNAL) of December/31,/2021
- what: The aim of treatment of DCIS is to prevent recurrence . This study was designed to evaluate how effective current test eligibility parameters are in identifying women with germline mutations in cancer predisposition genes, uptake and timing of genetic testing, choice of risk-reducing surgery in those with PV and second cancer events (SCE) in a cohort of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.